CK0801

· Cellenkos, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CK0801, covering 2025-04-13 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: CK0801 for Treatment of Aplastic Anemia [Phase 2]